Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations

Comment

P Gaut et al. Clin Infect Dis. 1999 Oct.

. 1999 Oct;29(4):784-6.

doi: 10.1086/520434.

No abstract available

Comment on

Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Torre-Cisneros J, De la Mata M, Pozo JC, Serrano P, Briceño J, Solórzano G, Miño G, Pera C, Sánchez-Guijo P. Torre-Cisneros J, et al. Clin Infect Dis. 1999 Oct;29(4):771-4. doi: 10.1086/520432. Clin Infect Dis. 1999. PMID: 10589886 Clinical Trial.
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL, Sherer R, Crane L, Labriola A, Caras S, Pulling C, Hafner R. El-Sadr WM, et al. Clin Infect Dis. 1999 Oct;29(4):775-83. doi: 10.1086/520433. Clin Infect Dis. 1999. PMID: 10589887 Clinical Trial.